131 related articles for article (PubMed ID: 10963832)
1. S20G mutation of the amylin gene in Japanese patients with type 2 diabetes.
Hayakawa T; Nagai Y; Ando H; Yamashita H; Takamura T; Abe T; Nomura G; Kobayashi KI
Diabetes Res Clin Pract; 2000 Aug; 49(2-3):195-7. PubMed ID: 10963832
[No Abstract] [Full Text] [Related]
2. S20G mutation of the amylin gene is associated with a lower body mass index in Korean type 2 diabetic patients.
Cho YM; Kim M; Park KS; Kim SY; Lee HK
Diabetes Res Clin Pract; 2003 May; 60(2):125-9. PubMed ID: 12706321
[TBL] [Abstract][Full Text] [Related]
3. S20G mutation of the amylin gene is associated with Type II diabetes in Japanese. Study Group of Comprehensive Analysis of Genetic Factors in Diabetes Mellitus.
Seino S;
Diabetologia; 2001 Jul; 44(7):906-9. PubMed ID: 11508277
[TBL] [Abstract][Full Text] [Related]
4. [S20G mutation of amylin gene--amyloid diabetes due to S20G amylin gene mutation].
Sanke T; Sakagashira S
Nihon Rinsho; 2005 Feb; 63 Suppl 2():160-5. PubMed ID: 15779362
[No Abstract] [Full Text] [Related]
5. Glucose tolerance in Japanese subjects with S20G mutation of the amylin gene.
Yamada K; Yuan X; Ishiyama S; Nonaka K
Diabetologia; 1998 Jan; 41(1):125. PubMed ID: 9498642
[No Abstract] [Full Text] [Related]
6. Nonsense mutation of islet-1 gene (Q310X) found in a type 2 diabetic patient with a strong family history.
Shimomura H; Sanke T; Hanabusa T; Tsunoda K; Furuta H; Nanjo K
Diabetes; 2000 Sep; 49(9):1597-600. PubMed ID: 10969846
[TBL] [Abstract][Full Text] [Related]
7. Missense mutation of amylin gene (S20G) in Japanese NIDDM patients.
Sakagashira S; Sanke T; Hanabusa T; Shimomura H; Ohagi S; Kumagaye KY; Nakajima K; Nanjo K
Diabetes; 1996 Sep; 45(9):1279-81. PubMed ID: 8772735
[TBL] [Abstract][Full Text] [Related]
8. Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide.
Ma Z; Westermark GT; Sakagashira S; Sanke T; Gustavsson A; Sakamoto H; Engström U; Nanjo K; Westermark P
Amyloid; 2001 Dec; 8(4):242-9. PubMed ID: 11791616
[TBL] [Abstract][Full Text] [Related]
9. Amylin S20G mutation in Mexican population.
Garcia-Gonzalez CL; Montoya-Fuentes H; Padilla-Rosas M; Sanchez-Corona J
Diabetes Res Clin Pract; 2007 Apr; 76(1):146-8. PubMed ID: 16950544
[TBL] [Abstract][Full Text] [Related]
10. The islet amyloid polypeptide (amylin) gene S20G mutation in Chinese subjects: evidence for associations with type 2 diabetes and cholesterol levels.
Lee SC; Hashim Y; Li JK; Ko GT; Critchley JA; Cockram CS; Chan JC
Clin Endocrinol (Oxf); 2001 Apr; 54(4):541-6. PubMed ID: 11318791
[TBL] [Abstract][Full Text] [Related]
11. Role of S20G mutation of amylin gene in insulin secretion, insulin sensitivity, and type II diabetes mellitus in Taiwanese patients.
Chuang LM; Lee KC; Huang CN; Wu HP; Tai TY; Lin BJ
Diabetologia; 1998 Oct; 41(10):1250-1. PubMed ID: 9794116
[No Abstract] [Full Text] [Related]
12. S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin.
Sakagashira S; Hiddinga HJ; Tateishi K; Sanke T; Hanabusa T; Nanjo K; Eberhardt NL
Am J Pathol; 2000 Dec; 157(6):2101-9. PubMed ID: 11106582
[TBL] [Abstract][Full Text] [Related]
13. Familial early-onset type 2 diabetes in Chinese patients: obesity and genetics have more significant roles than autoimmunity.
Ng MC; Lee SC; Ko GT; Li JK; So WY; Hashim Y; Barnett AH; Mackay IR; Critchley JA; Cockram CS; Chan JC
Diabetes Care; 2001 Apr; 24(4):663-71. PubMed ID: 11315828
[TBL] [Abstract][Full Text] [Related]
14. Fibril structures of diabetes-related amylin variants reveal a basis for surface-templated assembly.
Gallardo R; Iadanza MG; Xu Y; Heath GR; Foster R; Radford SE; Ranson NA
Nat Struct Mol Biol; 2020 Nov; 27(11):1048-1056. PubMed ID: 32929282
[TBL] [Abstract][Full Text] [Related]
15. [The impact of the missense mutation-ser20gly in islet amyloid polypeptide gene on NIDDM in Chinese].
Xiang K; Zheng T; Lu H
Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):817-20. PubMed ID: 11038774
[TBL] [Abstract][Full Text] [Related]
16. Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
Kahn SE; Verchere CB; Andrikopoulos S; Asberry PJ; Leonetti DL; Wahl PW; Boyko EJ; Schwartz RS; Newell-Morris L; Fujimoto WY
Diabetes; 1998 Apr; 47(4):640-5. PubMed ID: 9568698
[TBL] [Abstract][Full Text] [Related]
17. Amylin gene promoter mutations predispose to Type 2 diabetes in New Zealand Maori.
Poa NR; Cooper GJ; Edgar PF
Diabetologia; 2003 Apr; 46(4):574-8. PubMed ID: 12679865
[TBL] [Abstract][Full Text] [Related]
18. Islet amyloid polypeptide gene: no evidence of abnormal promoter region in thirty-five type 2 diabetic patients.
Tokuyama Y; Kanatsuka A; Suzuki Y; Yamaguchi T; Taira M; Makino H; Yoshida S
Diabetes Res Clin Pract; 1994 Jan; 22(2-3):99-105. PubMed ID: 8200302
[TBL] [Abstract][Full Text] [Related]
19. [Islet amyloid polypeptide (IAPP)].
Sanke T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():545-7. PubMed ID: 16149573
[No Abstract] [Full Text] [Related]
20. Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus.
Roberts AN; Leighton B; Todd JA; Cockburn D; Schofield PN; Sutton R; Holt S; Boyd Y; Day AJ; Foot EA
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9662-6. PubMed ID: 2690069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
